MRNS — Marinus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $30.34m
- $43.35m
- $30.99m
Brief: Immedica To Acquire Biopharmaceutical Company Marinus Pharmaceuticals
Marinus Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Appfolio, S&P Global, Uber
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Marinus hits record low after discontinuing development of rare disease drug
U.S. STOCKS ON THE MOVE-Teck Resources, Nasdaq, T-Mobile
U.S. STOCKS ON THE MOVE-United Parcel Service, Boeing
Marinus plummets after discontinuing development of rare disease drug
Marinus Pharma to explore options as rare disease drug fails trial (updated)
Marinus Pharma to explore options as rare disease drug fails trial
Brief: Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 Raise Trial In Refractory Status Epilepticus At The Neurocritical Care Society 2024 Annual Meeting
Brief: Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Cardinal Health, Factset, Paylocity Holding
U.S. STOCKS ON THE MOVE-Paysafe, HUYA, Oklo
U.S. STOCKS ON THE MOVE-Penumbra, Talen Energy, Paysafe
Marinus Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Apollomics, Syros Pharmaceuticals, Buzzfeed
Marinus Pharma falls after missing Q2 revenue estimates
Marinus Pharmaceuticals Inc expected to post a loss of 59 cents a share - Earnings Preview